Viva Biotech buys back 0.61 million shares on 18 May; May total reaches 10.82 million pending cancellation

Bulletin Express

May 18

Viva Biotech Holdings disclosed that on 18 May 2026 it repurchased 0.61 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.40 to HKD 1.43, for a total consideration of HKD 0.86 million. All repurchased shares are intended for cancellation.

Including the latest transaction, the company has bought back 10.82 million shares between 8 May and 18 May 2026 at volume-weighted average prices between HKD 1.40 and HKD 1.57. These shares have not yet been cancelled and represent 0.51 % of the share capital approved for repurchase under the mandate granted on 12 June 2025 (maximum 212.84 million shares).

The repurchases did not alter the issued share count during the reporting period: outstanding shares stood at 2.13 billion both before and after the 18 May cut-off. Under Hong Kong listing rules, Viva Biotech is subject to a moratorium on issuing new shares until 17 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1125851262"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1125851262\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1125851262?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 18:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125851262","market":"us","top_or_hot":-1,"title":"Viva Biotech buys back 0.61 million shares on 18 May; May total reaches 10.82 million pending cancellation","media":"Bulletin Express","content":"<p>Viva Biotech Holdings disclosed that on 18 May 2026 it repurchased 0.61 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.40 to HKD 1.43, for a total consideration of HKD 0.86 million. All repurchased shares are intended for cancellation.</p>\n<p>Including the latest transaction, the company has bought back 10.82 million shares between 8 May and 18 May 2026 at volume-weighted average prices between HKD 1.40 and HKD 1.57. These shares have not yet been cancelled and represent 0.51 % of the share capital approved for repurchase under the mandate granted on 12 June 2025 (maximum 212.84 million shares).</p>\n<p>The repurchases did not alter the issued share count during the reporting period: outstanding shares stood at 2.13 billion both before and after the 18 May cut-off. Under Hong Kong listing rules, Viva Biotech is subject to a moratorium on issuing new shares until 17 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viva Biotech buys back 0.61 million shares on 18 May; May total reaches 10.82 million pending cancellation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViva Biotech buys back 0.61 million shares on 18 May; May total reaches 10.82 million pending cancellation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-18 18:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Viva Biotech Holdings disclosed that on 18 May 2026 it repurchased 0.61 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.40 to HKD 1.43, for a total consideration of HKD 0.86 million. All repurchased shares are intended for cancellation.</p>\n<p>Including the latest transaction, the company has bought back 10.82 million shares between 8 May and 18 May 2026 at volume-weighted average prices between HKD 1.40 and HKD 1.57. These shares have not yet been cancelled and represent 0.51 % of the share capital approved for repurchase under the mandate granted on 12 June 2025 (maximum 212.84 million shares).</p>\n<p>The repurchases did not alter the issued share count during the reporting period: outstanding shares stood at 2.13 billion both before and after the 18 May cut-off. Under Hong Kong listing rules, Viva Biotech is subject to a moratorium on issuing new shares until 17 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01873","symbol_name":"维亚生物","start_time":0,"source_url":"","article_id":"1125851262","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125851262","pubTimestamp":1779100956,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Viva Biotech Holdings disclosed that on 18 May 2026 it repurchased 0.61 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.40 to HKD 1.43, for a total consideration...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01873":"维亚生物"},"translate_title":"维亚生物于5月18日回购61万股；5月待取消总数达1082万","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01873":1},"content_text":"Viva Biotech Holdings disclosed that on 18 May 2026 it repurchased 0.61 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 1.40 to HKD 1.43, for a total consideration of HKD 0.86 million. All repurchased shares are intended for cancellation.\nIncluding the latest transaction, the company has bought back 10.82 million shares between 8 May and 18 May 2026 at volume-weighted average prices between HKD 1.40 and HKD 1.57. These shares have not yet been cancelled and represent 0.51 % of the share capital approved for repurchase under the mandate granted on 12 June 2025 (maximum 212.84 million shares).\nThe repurchases did not alter the issued share count during the reporting period: outstanding shares stood at 2.13 billion both before and after the 18 May cut-off. Under Hong Kong listing rules, Viva Biotech is subject to a moratorium on issuing new shares until 17 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}